Center-Authored Papers

Filters: Author is Gallinger, Steve  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
Whiffin N, Dobbins SE, Hosking FJ, Palles C, Tenesa A, Wang Y, Farrington SM, Jones AM, Broderick P, Campbell H et al..  2013.  Deciphering the genetic architecture of low-penetrance susceptibility to colorectal cancer.. Human molecular genetics. 22(24):5075-82. Abstract
Whiffin N, Hosking F, Farrington SM, Palles C, Dobbins S, Zgaga L, Lloyd A, Kinnersley B, Gorman M, Tenesa A et al..  2014.  Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis.. Human molecular genetics. Abstract
Wang H, Taverna D, Stram DO, Fortini BK, Cheng I, Wilkens LR, Burnett T, Makar KW, Lindor NM, Hopper JL et al..  2013.  Genetic variation in the inflammation and innate immunity pathways and colorectal cancer risk.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 22(11):2094-101. Abstract
P
Pande M, Lynch PM, Hopper JL, Jenkins MA, Gallinger S, Haile RW, Le Marchand L, Lindor NM, Campbell PT, Newcomb PA et al..  2010.  Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center.. Clinical cancer research : an official journal of the American Association for Cancer Research. 16(4):1331-9. Abstract
O
Orlando G, Law PJ, Palin K, Tuupanen S, Gylfe A, Hänninen U, Cajuso T, Tanskanen T, Kondelin J, Kaasinen E et al..  2016.  Variation at 2q35 (PNKD and TMBIM1) influences colorectal cancer risk and identifies a pleiotropic effect with inflammatory bowel disease.. Human molecular genetics. Abstract
L
Lindor NM, Yang P, Evans I, Schowalter K, de Andrade M, Li J, Jeavons E, Peterson G, Gallinger S, Bapat B et al..  2010.  Alpha-1-antitrypsin deficiency and smoking as risk factors for mismatch repair deficient colorectal cancer: a study from the colon cancer family registry.. Molecular genetics and metabolism. 99(2):157-9. Abstract
J
Jarvis D, Mitchell JS, Law PJ, Palin K, Tuupanen S, Gylfe A, Hänninen UA, Cajuso T, Tanskanen T, Kondelin J et al..  2016.  Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer.. British journal of cancer. Abstract
G
Gray-McGuire C, Guda K, Adrianto I, Lin CP, Natale L, Potter JD, Newcomb PA, Poole EM, Ulrich CM, Lindor N et al..  2010.  Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22.. Cancer research. 70(13):5409-18. Abstract
D
Dowty JG, Win AK, Buchanan DD, Lindor NM, Macrae FA, Clendenning M, Antill YC, Thibodeau SN, Casey G, Gallinger S et al..  2013.  Cancer Risks for MLH1 and MSH2 Mutation Carriers.. Human mutation. 34(3):490-7. Abstract
C
Clendenning M, Walsh MD, Gelpi JB, Thibodeau SN, Lindor N, Potter JD, Newcomb P, Le Marchand L, Haile R, Gallinger S et al..  2013.  Detection of large scale 3' deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything? Familial cancer. 12(3):563-6. Abstract
Cheng TH, Thompson D, Painter J, O'Mara T, Gorman M, Martin L, Palles C, Jones A, Buchanan DD, Win AK et al..  2015.  Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.. Scientific reports. 5:17369. Abstract
B
Bapat B, Lindor NM, Baron J, Siegmund K, Li L, Zheng Y, Haile R, Gallinger S, Jass JR, Young JP et al..  2009.  The association of tumor microsatellite instability phenotype with family history of colorectal cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(3):967-75. Abstract
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AHJT, Cartwright NR, Barnetson RA, Farrington SM et al..  2010.  Risks of Lynch syndrome cancers for MSH6 mutation carriers.. Journal of the National Cancer Institute. 102(3):193-201. Abstract
A
Arem H, Yu K, Xiong X, Moy K, Freedman ND, Mayne ST, Albanes D, Arslan AA, Austin M, Bamlet WR et al..  2015.  Vitamin D metabolic pathway genes and pancreatic cancer risk.. PloS one. 10(3):e0117574. Abstract
Al-Tassan NA, Whiffin N, Hosking FJ, Palles C, Farrington SM, Dobbins SE, Harris R, Gorman M, Tenesa A, Meyer BF et al..  2015.  A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.. Scientific reports. 5:10442. Abstract